Cervical Cancer Screening Intervals, 2006 to 2009: Moving Beyond Annual Testing
Open Access
- 27 May 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (10) , 922-924
Abstract
Clinical guidelines recommend that women 30 years and older with a negative test result for oncogenic human papillomavirus (HPV) and with a concurrent normal Papanicolaou test result (co-testing) not be tested again for at least 3 years.1 Previous studies, however, indicate that primary care providers continue to perform annual testing regardless of prior test results.2,3 Our objective was to examine clinicians' reported behaviors regarding cervical cancer screening intervals over a 4-year period after the endorsement of co-testing.Keywords
This publication has 4 references indexed in Scilit:
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical CancerAmerican Journal of Clinical Pathology, 2012
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceThe Lancet Oncology, 2011
- American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and CancerCA: A Cancer Journal for Clinicians, 2002
- Comparison of Vignettes, Standardized Patients, and Chart Abstraction: A Prospective Validation Study of 3 Methods for Measuring QualityJAMA, 2000